Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.

The journal of allergy and clinical immunology. Global·2026
Same author

Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical Outcomes.

Clinical reviews in allergy & immunology·2026
Same author

Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.

The World Allergy Organization journal·2026
Same author

Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.

The New England journal of medicine·2026
Same author

Expert consensus on the long-term use of lanadelumab in hereditary angioedema: Toward harmonized care.

Allergologie select·2026
Same author

Garadacimab for the long-term prophylaxis of hereditary angioedema.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

Related Experiment Video

Updated: Jan 21, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.1K

[Hereditary angioedema].

Emel Aygören-Pürsün1, Konrad Bork2

  • 1Angioödem-Ambulanz und Comprehensive Care Center für hereditäres Angioödem, Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Frankfurt, Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Deutschland. aygoeren@em.uni-frankfurt.de.

Der Internist
|August 1, 2019
PubMed
Summary

Hereditary angioedema (HAE) is a group of lifelong, potentially life-threatening genetic conditions. Early diagnosis and individualized treatment with bradykinin antagonists are crucial for managing HAE symptoms and improving patient quality of life.

Keywords:
BradykininComplement C1 inhibitor proteinFactor XIIHereditary angioedemaProphylaxis, angioedema

More Related Videos

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
07:32

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

8.2K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.2K

Related Experiment Videos

Last Updated: Jan 21, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.1K
Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia
07:32

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

8.2K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.2K

Area of Science:

  • Genetics and immunology
  • Rare diseases
  • Clinical diagnostics

Background:

  • Hereditary angioedema (HAE) presents with diverse phenotypes linked to distinct genotypes.
  • Distinguishing HAE from histaminergic angioedema relies on specific clinical indicators.
  • HAE is a chronic, potentially fatal condition significantly impacting patient well-being.

Purpose of the Study:

  • To delineate the key diagnostic features differentiating HAE from other forms of angioedema.
  • To underscore the severity and lifelong nature of HAE.
  • To highlight the importance of personalized management strategies for HAE.

Main Methods:

  • Clinical observation and phenotypic analysis.
  • Genotypic correlation with disease presentation.
  • Review of treatment responses, including bradykinin antagonists.

Main Results:

  • Prolonged angioedema development, family history, and lack of response to antihistamines/steroids are indicative of HAE.
  • HAE subtypes can manifest with severe clinical courses.
  • Bradykinin antagonists demonstrate efficacy in HAE management.

Conclusions:

  • Accurate HAE diagnosis is critical due to its severe and potentially life-threatening nature.
  • Individualized treatment plans, supported by available specific medications, are essential for managing HAE.
  • Understanding HAE's genetic heterogeneity aids in tailored therapeutic approaches.